The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authorisation drug Remdesivir. For this reason, Joint
Monitoring Group under Chairmanship of DGHS took into consideration findings of the
followi...ng studies to issue this advisory:
more
conducted for the World Economic Forum
Key findings from a February 2021 survey from the Partnership for Evidence-Based Response to COVID-19 (PERC)
AWMF Leitlinie, 12.7.2021
The Platform has functionality for country-level users, such as uploading theNational Deployment and Vaccination Planon the Info tab by the WCO vaccine expert, followed by validation by a government official. The Platform has functionality for regional users, such as Reviewingof National Deployment ...and Vaccination Plan(NDVP) on the Action Checklist tabor uploading a summary of the review of the NDVP on the Info tab and within the NDVP folder.
more
On March 1, 2021, the countries of the Americas began receiving vaccines through the COVAX Mechanism, an unprecedented global effort between CEPI, Gavi, Unicef, PAHO, and WHO to ensure equitable access to immunization throughout the world. The PAHO Revolving Fund is the mechanism designated by COVA...X to procure the vaccines on behalf of the countries in the region.
— Data on vaccine doses administered in the Americas
more
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are supported by decades of medical research. ...They work by preparing the body's own immune system to recognise and defend against a specific disease. The volume of information available about vaccination can be overwhelming, so it’s important to talk through the topic.
Available in different languages
more
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
Guidelines on intubation of Orotraqueal in patients with COV-19
Diese Informationen sind zur Weitergabe an Patient:innen und Bürger:innen.
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. L’arrêt de la propagation du virus à la source res...te essentiel. Les mesures actuelles visant à réduire la transmission du virus – dont le lavage fréquent des mains, le port du masque, la distanciation physique et le fait d’éviter de se rendre dans les lieux très fréquentés ou fermés – restent efficaces contre les nouveaux variants car elles réduisent la transmission du virus, qui a donc moins de possibilités de muter. Grâce aux notes explicatives de l’OMS sur les vaccins, en savoir plus sur les vaccins, sur leur fonctionnement et sur la façon dont ils sont fabriqués pour en garantir l’innocuité et y permettre un accès équitable.
more
YouTube influencer Healthcare Triage talked with WHO's Dr Kate O'Brien about how the COVID-19 vaccine works, how it gets distributed, and how we distribute it equitably.
1:27 Safety questions and concerns about quick development of the vaccine.
7:18 Have we entered a new age where all vaccines wi...ll be developed this easily and quickly?
8:41 Questions about vaccine distribution – how’s it gonna work?
10:36 How do we make sure we distribute the vaccine equitably?
11:59 How do we make sure all countries get the same seat at the vaccine table?
13:29 What are reasonable expectations about the vaccine and life returning to “normal”?
15:14 Misinformation about the vaccine
17:00 Specific myths about the vaccine
18:18 The bigger picture – what have we learned from this pandemic that we should apply in the future?
more
Empfehlungen f ür das politische Handeln des Bundes und der Länder so wie angeschlossene Behörden
Version 01, veröffentlichtam 16.12.2020
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
Availble in different languages
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are a critical tool in the battl...e against COVID-19, and getting vaccinated is one of the best ways to protect yourself and others from COVID-19.
more
13 April 2021 Policy Brief